Search Results - Anthony M. Joshua
- Showing 1 - 12 results of 12
-
1
Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS). by Bethany Pitcher, Leila Khoja, Robert J Hamilton, Kald Abdallah, Melania Pintilie, Anthony M Joshua
Published in PLoS ONE (2017-01-01)Get full text
Article -
2
Uncertainty and hope in people with metastatic uveal melanoma in the era of immunotherapy and targeted treatments: a theory-based qualitative study by Tim Luckett, Carrie-Anne Ng, Julia Lai-Kwon, Damien Kee, Brendan Mulhern, Anthony M. Joshua
Published in BMC Cancer (2025-05-01)Get full text
Article -
3
Circulating Tumour DNA Biomarkers Associated with Outcomes in Metastatic Prostate Cancer Treated with Lutetium-177-PSMA-617 by Megan Crumbaker, Leonard D. Goldstein, David H. Murray, Jiang Tao, Sarennya Pathmanandavel, Nicky Boulter, Lalith Ratnayake, Anthony M. Joshua, Sarah Kummerfeld, Louise Emmett
Published in European Urology Open Science (2023-11-01)Get full text
Article -
4
Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: L... by Lisa M Butler, Anthony M Joshua, Tahlia Scheinberg, James Kench, Martin Stockler, Kate L Mahon, Lucille Sebastian, Phillip Stricker, H Woo, Ruban Thanigasalam, Nariman Ahmadi, Margaret M Centenera, Lisa G Horvath
Published in BMJ Open (2020-01-01)Get full text
Article -
5
Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial by Rui M. Bernardino, Leyi B. Yin, Katherine Lajkosz, Eric Winquist, Jessica G. Cockburn, Pocharapong Jenjitranant, Rosette Veloso, Clare ÓConnell, Aurora Mejia Benitez, David-Dan Nguyen, Rune Matthiesen, Rui Henrique, Anthony M. Joshua, Theodorus van der Kwast, Neil E. Fleshner
Published in European Urology Open Science (2025-12-01)Get full text
Article -
6
Cancer patients’ experiences with immune checkpoint modulators: A qualitative study by Kari Ala‐Leppilampi, Natalie A. Baker, Chris McKillop, Marcus O. Butler, Lillian L. Siu, Anna Spreafico, Albiruni R. Abdul Razak, Anthony M. Joshua, David Hogg, Philippe L. Bedard, Natasha Leighl, Amit M. Oza, Janet A. Parsons, Aaron R. Hansen
Published in Cancer Medicine (2020-05-01)Get full text
Article -
7
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT) by Louise Emmett, Nikeith John, Sarennya Pathmanandavel, William Counter, Maria Ayers, Shikha Sharma, Shikha Agrawal, Aron Poole, Elizabeth Hovey, Ganes Pranavan, Craig Gedye, Girish Mallesara, Alex Guminski, Adrian Lee, Martin R. Stockler, Adam Hickey, Peter Eu, Anthony M. Joshua, Megan Crumbaker, Andrew Nguyen
Published in Therapeutic Advances in Medical Oncology (2023-03-01)Get full text
Article -
8
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue by Linh T. Nguyen, Charlotte S. Lo, Michael Fyrsta, Jessica Nie, Jennifer Y. Yam, Pei-Hua Yen, Michael X. Le, Karen Hersey, Miran Kenk, Megan Crumbaker, Neil Fleshner, Girish Kulkarni, Robert Hamilton, Michael Jewett, Antonio Finelli, Andrew Evans, Joan Sweet, Pamela S. Ohashi, Anthony M. Joshua
Published in Prostate Cancer (2022-01-01)Get full text
Article -
9
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation by Subotheni Thavaneswaran, Frank Lin, John P. Grady, David Espinoza, Min Li Huang, Sarah Chinchen, Lucille Sebastian, Maya Kansara, Tony Mersiades, Chee Khoon Lee, Jayesh Desai, Peter Grimison, Michael Brown, Michael Millward, Rosemary Harrup, Ken O’Byrne, Adnan Nagrial, Paul Craft, John Simes, Anthony M. Joshua, David M. Thomas
Published in npj Precision Oncology (2024-09-01)Get full text
Article -
10
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors by Sujun Chen, Jessica Petricca, Wenbin Ye, Jiansheng Guan, Yong Zeng, Nicholas Cheng, Linsey Gong, Shu Yi Shen, Junjie T. Hua, Megan Crumbaker, Michael Fraser, Stanley Liu, Scott V. Bratman, Theodorus van der Kwast, Trevor Pugh, Anthony M. Joshua, Daniel D. De Carvalho, Kim N. Chi, Philip Awadalla, Guoli Ji, Felix Feng, Alexander W. Wyatt, Housheng Hansen He
Published in Nature Communications (2022-10-01)Get full text
Article -
11
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial by Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani
Published in Journal for ImmunoTherapy of Cancer (2022-04-01)Get full text
Article -
12
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial by Tracy L. Stockley, Amit M. Oza, Hal K. Berman, Natasha B. Leighl, Jennifer J. Knox, Frances A. Shepherd, Eric X. Chen, Monika K. Krzyzanowska, Neesha Dhani, Anthony M. Joshua, Ming-Sound Tsao, Stefano Serra, Blaise Clarke, Michael H. Roehrl, Tong Zhang, Mahadeo A. Sukhai, Nadia Califaretti, Mateya Trinkaus, Patricia Shaw, Theodorus van der Kwast, Lisa Wang, Carl Virtanen, Raymond H. Kim, Albiruni R. A. Razak, Aaron R. Hansen, Celeste Yu, Trevor J. Pugh, Suzanne Kamel-Reid, Lillian L. Siu, Philippe L. Bedard
Published in Genome Medicine (2016-10-01)Get full text
Article
